Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03556579
Other study ID # CR-6100
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 15, 2018
Est. completion date September 20, 2018

Study information

Verified date October 2019
Source Johnson & Johnson Vision Care, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a single-site, two-visit, contralateral, non-dispensing, randomized, controlled and subject-masked study to measure potential benefits of the new UV blocker.


Recruitment information / eligibility

Status Completed
Enrollment 62
Est. completion date September 20, 2018
Est. primary completion date September 20, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Potential subjects must satisfy all of the following criteria to be enrolled in the study:

1. The subject must read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form.

2. Appear able and willing to adhere to the instructions set forth in this clinical protocol

3. Between 18 and 65 (inclusive) years of age at the time of screening.

4. Be a current spherical soft silicone hydrogel contact lens wearer in both eyes with a minimum of 6 hours/day and 5 days/week wear time over the last 30 days by self-report.

5. The subject's vertex-corrected spherical equivalent distance refraction must be in the range of -1.00 through -4.50 D in each eye.

6. The subject has a best corrected visual acuity of 20/25 or better in each eye.

Exclusion Criteria:

1. Currently pregnant or breastfeeding.

2. Any ocular or systemic allergies or diseases that may interfere with contact lens wear.

3. Any autoimmune disease or use of medication, which may interfere with contact lens wear. Habitual medications used by successful soft contact lens wearers are considered acceptable.

4. Entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, or aphakia.

5. Any previous, or planned, ocular or interocular surgery (e.g., radial keratotomy, PRK, LASIK, etc.).

6. Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.

7. Multifocal, toric or extended wear contact lens correction.

8. Participation in any contact lens or lens care product clinical trial within 14 days prior to study enrollment.

9. History of binocular vision abnormality or strabismus.

10. Any infectious disease (e.g., hepatitis, tuberculosis) or contagious immunosuppressive diseases (e.g., HIV) by self-report.

11. Employee or immediate family member of an employee of clinical site (e.g., Investigator, Coordinator, Technician).

12. Any ocular infection.

13. Any grade 3 or greater slit lamp findings (e.g., edema, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival injection) on the FDA classification scale, any previous history or signs of a contact lens-related corneal inflammatory event (e.g., past peripheral ulcer or round peripheral scar), or any other ocular abnormality that may contraindicate contact lens wear.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
senofilcon A with new UV blocker
Test Lens
senofilcon A
Control Lens

Locations

Country Name City State
United States Georgia Center for Sight Statesboro Georgia

Sponsors (1)

Lead Sponsor Collaborator
Johnson & Johnson Vision Care, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Two-Point Light Spread Function The two-point light spread function was assessed at visit 2 for each subject eye under two conditions with a distance filter and without a distance filter. Measurements for this metric were taken twice, with the presence of an additional UV/HEV light source and without this additional light source (the same study lenses were used for both measurements). Two-point light spread function is defined that the as the minimum distance (mm) that two points of light are completely distinct. Measurements for this metric are positive. Smaller distances indicate better lens performance. The average distance for each lens type and light source combination was reported across age groups. Between 5 minutes and 3 hours Post Lens Insertion, at Visit 2
Primary Halos The appearance of Halos was assessed at visit 2 for each subject eye. Measurements for this metric were taken twice, with the presence of an additional UV/HEV light source and without this additional light source (the same study lenses were used for both measurements). Halos were quantified as the diameter (mm) of the outer edges of the Halo. Measurements for this metric are positive. Smaller diameter indicates better lens performance. The average diameter (mm) for each lens type and light source combination was reported across age groups. Between 5 minutes and 3 hours Post Lens Insertion, at Visit 2
Primary Starburts The appearance of starbursts was assessed at visit 2 for each subject eye. Measurements for this metric were taken twice, with the presence of an additional UV/HEV light source and without this additional light source (the same study lenses were used for both measurements). Starbursts are defined as the diameter (mm) of the light's lateral spread. Measurements for this metric are positive. Smaller diameter indicates better lens performance. The average diameter (mm) for each lens type and light source combination was reported across age groups. Between 5 minutes and 3 hours Post Lens Insertion, at Visit 2
Secondary Glare Disability Threshold The Glare disability threshold was assessed for each eye at visit 1. The study lenses in this visit were assessed without the additional light sourced used at visit 2. Subjects were exposed to a target stimulus for 2 seconds; before the measurement was taken the annulus was set to a level below that which would cause the target stimulus to be veiled. The experimenter would then adjust the intensity of the annulus until subjects could no longer see the target stimulus. Subjects would indicate this by pressing a buzzer. Glare disability thresholds take on positive values, where higher values indicate better lens performance. The average glare disability level (change in log relative energy) for each lens type was reported across age groups. Between 5 minutes and 3 hours Post Lens Insertion, at Visit 1
Secondary Photostress Recovery Time Photostress Recovery (PR) Time (seconds) was assessed for each eye at visit 1. The study lenses in this visit were assessed without the additional light sourced used at visit 2. Subjects are exposed to a target, once the target was able to be comfortable viewed by the subject, a bright bleaching light covered it. As the afterimage fades, participants will gradually be able to re-gain sight of the target. PR time will be recorded as the time it takes following exposure to the bleaching light to regain sight of the target. PR Times are positive values where smaller times indicate better lens performance. The average PR Time (seconds) for each lens type was reported across age groups. Between 5 minutes and 3 hours Post Lens Insertion, at Visit 1
Secondary Glare Discomfort The Glare discomfort (change in palpebral fissure height) was assessed for each eye at visit 1. The study lenses in this visit were assessed without the additional light sourced used at visit 2. Glare discomfort can take on negative and positive values, where smaller values indicate better lens performance. The average glare discomfort (change in palpebral fissure height) for each lens type was reported across age groups. Between 5 minutes and 3 hours Post Lens Insertion, at Visit 1
Secondary Heterochromatic Contrast Threshold Heterochromatic Contrast Threshold was assessed for each eye at visit 1. The study lenses in this visit were assessed without the additional light sourced used at visit 2. Heterochromatic contrast thresholds are measured as thresholds to a variable wavelength central target presented on a short-wave (460nm) sky-light background. Thresholds are positive values, where higher values indicate better lens performance. The average threshold each lens type was reported across age groups. Between 5 minutes and 3 hours Post Lens Insertion, at Visit 1
See also
  Status Clinical Trial Phase
Completed NCT04532099 - Clinical Comparison of Two Daily Wear Frequent Replacement Silicone Hydrogel Soft Contact Lenses N/A
Completed NCT03319212 - Clinical Characterization of Symptomatic Populations N/A
Withdrawn NCT04525170 - Clinical Evaluation of HPT Treated Rigid Contact Lenses Made From Hexafocon A N/A
Completed NCT05483127 - Clinical Comparison of Two Daily Disposable Toric Soft Contact Lenses N/A
Completed NCT01741987 - Osmoprotective Containing Lubricants in Dysfunctional Tear Syndrome and Post Refractive Surgery Patients N/A
Completed NCT03688672 - Apioc Contact Lens Feasibility N/A
Completed NCT02312323 - One-month Clinical Evaluation of Silicone Hydrogel Definitive 65 HPT Contact Lenses N/A
Recruiting NCT04714424 - Comparing Vision Tests in a Virtual Reality Headset to Existing Analogues
Recruiting NCT04632784 - Clinical Trial With Artiflex Presbyopic N/A
Completed NCT04185701 - Comparison of Subjective Refraction Measurement With SiVIEW Software and by an Expert N/A
Completed NCT01706770 - Evaluation of Enfilcon A Soft Contact Lens When Compared to Galyfilcon A Soft Contact Lens N/A
Completed NCT04654455 - Prospective Study Evaluating Dry Eye in Patients Operated on for Ametropia by LASIK Surgery and Treated With REPADROP
Not yet recruiting NCT06295536 - Optimization of a Photoretinoscopy Method for Determining the Objective Refraction of Children N/A
Completed NCT00691197 - Safety and Acceptability of Using a Rewetting Drop With Contact Lens Wear Phase 2/Phase 3
Completed NCT00597467 - Study of Soft Contact Lens Use With 7 Day Extended Wear N/A
Completed NCT04067141 - The Clinical Comparison of Somofilcon A 1 Day and Nelfilcon A Daily Disposable Contact Lenses N/A
Completed NCT04067050 - A Clinical Study of the Comfilcon A Asphere Soft Contact Lens in Users of Digital Devices N/A
Not yet recruiting NCT06408649 - Post-market Clinical Follow-up Study of Alcon TOTAL30® Contact Lenses (Lehfilcon A)
Completed NCT02553681 - Clinical Evaluation of HPT Treated Rigid Contact Lenses Made From Roflufocon D N/A
Completed NCT00722891 - Ocular Responses to Short and Long-term Lens Wear N/A